skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Financial Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

IFI Logo
Search Icon RecommendationseCommerce StoreProduct loginProductLogin
Global Search Configuration

About Ken

USA

+49 year(s) experience

Ken’s coverage includes the primary and secondary investment grade corporate issuance market. Aside from maintaining and publishing very detailed issuance statistics, he anticipates and analyzes the trends in the high-grade new issue market through his statistical morning report (Daily Informa), his morning commentary (Morning Call) and weekly newsletter (In a Nutshell).
Ken joined us in 2005 and focuses mainly on the US Investment Grade new issue bond market. He draws on his 26+ years of experience as an institutional bond trader to relate to the needs of IGM's clients.

His early career on the Street started in the corporate syndicate department of Halsey Stuart & Co and eventually led to a trading position.

On leaving Halsey (Bache) in 1976, Ken joined Whiteweld as VP in charge of floating rate note syndication and trading. From there, he held similar positions in firms in New York and London before retiring from trading in 1997.

Ken honed his editorial skills two years as senior and managing editor of Financial Trader magazine. He was also a Senior Analyst at IFR Markets for five years covering the high grade markets.

Specialties

  • Credit

Analyst Articles

Articles by Ken

  • IGM Credit

    THE US INVESTMENT GRADE NEW ISSUE MARKET

    THE US INVESTMENT GRADE NEW ISSUE MARKET

    As a result of the Covid-19 induced lockdowns, many cash-strapped corporations - those who could - descended on the US public debt market in droves, raising an unprecedented $723bln in Q2 2020. That brought ex-SSA H1 issuance to an unheard of $1,214,331bln, topping all estimates for the year. Fun fact: 2020 high grade issuance is running 101.8% higher than last year at this time. Along the way, many milestones were set including a quarter that produced (1) three of the top six busiest ex-SSA issuance months on record (2) the busiest ex-SSA issuance month on record (April’s $297.775bln) (3) and needless to say, the busiest issuance quarter, and half, of all time ($723.121bln and $1,214,331bln respectively).

    Topic Industry News

    Read blog